Literature DB >> 20171215

High density lipoprotein inhibits the activation of sterol regulatory element-binding protein-1 in cultured cells.

Masaki Yoshida1, Nagakatsu Harada, Keiko Yoshida, Tadahiko Nakagawa, Takaaki Shimohata, Kazuaki Mawatari, Akira Takahashi, Hiroshi Sakaue, Yutaka Nakaya.   

Abstract

A link between cellular uptake of high density lipoprotein (HDL) and regulation of sterol regulatory element-binding protein-1 (SREBP-1) was investigated in vitro. HDL decreased nuclear SREBP-1 levels as well as SREBP-1 target gene expression in HepG2 and HEK293 cells. However, HDL did not repress an exogenously expressed, constitutively active form of SREBP-1. HDL increased cellular cholesterol levels, and cellular cholesterol depletion by methyl-beta-cyclodextrin abolished the effects of HDL. These results suggest that HDL inhibits the activation of SREBP-1 through a cholesterol-dependent mechanism, which may play an important role in regulating lipid synthetic pathways mediated by SREBP-1. Copyright 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20171215     DOI: 10.1016/j.febslet.2010.02.034

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  2 in total

Review 1.  The effect of statins on the organs: similar or contradictory?

Authors:  Yasin Ahmadi; Amir Ghorbanihaghjo; Hassan Argani
Journal:  J Cardiovasc Thorac Res       Date:  2017-06-29

2.  A new nutraceutical (Livogen Plus®) improves liver steatosis in adults with non-alcoholic fatty liver disease.

Authors:  Yvelise Ferro; Roberta Pujia; Elisa Mazza; Lidia Lascala; Oscar Lodari; Samantha Maurotti; Arturo Pujia; Tiziana Montalcini
Journal:  J Transl Med       Date:  2022-08-19       Impact factor: 8.440

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.